Ö. ERCELEP Et Al. , "Smokers having Activating EGFR Mutant Non-Small CellLung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience," TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.3, pp.334-339, 2020
ERCELEP, Ö. Et Al. 2020. Smokers having Activating EGFR Mutant Non-Small CellLung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience. TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.3 , 334-339.
ERCELEP, Ö., AKIN TELLİ, T., ALAN, Ö., Hasanov, R., Şimşek, E. T., Babacan, N., ... Kaya, S.(2020). Smokers having Activating EGFR Mutant Non-Small CellLung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience. TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.3, 334-339.
ERCELEP, ÖZLEM Et Al. "Smokers having Activating EGFR Mutant Non-Small CellLung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience," TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.3, 334-339, 2020
ERCELEP, ÖZLEM Et Al. "Smokers having Activating EGFR Mutant Non-Small CellLung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience." TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.3, pp.334-339, 2020
ERCELEP, Ö. Et Al. (2020) . "Smokers having Activating EGFR Mutant Non-Small CellLung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience." TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.3, pp.334-339.
@article{article, author={ÖZLEM ERCELEP Et Al. }, title={Smokers having Activating EGFR Mutant Non-Small CellLung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience}, journal={TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY}, year=2020, pages={334-339} }